Telix Pharmaceuticals (ASX: TSX, NASDAQ: TSX) shines with 139% annual stock growth! European approval for Illuccix® boosts its global presence in oncology innovation. Discover why TLX is a top healthcare stock. #HealthcareInnovation #stocks #ASX #NASDAQ
#healthcareinnovation
#HealthcareInnovation #stocks #ASX #NASDAQ